The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer

Clinical trial NCT06439693 · RECRUITING

Trial details

NCT number: NCT06439693
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Female Breast Cancer Breast Cancer Metastatic Estrogen Receptor-positive Breast Cancer HER2-positive Breast Cancer Stage IV Breast Cancer

Start date: 2024-08-08
Primary completion: 2030-03-30
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.